Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods
Disease area: Airway diseases, Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Ozlem Kar Kurt (Ankara, Turkey), Meside Gunduzoz, Özlem Kar Kurt, Turkan Nadir Ozis, Ceylan Bal, Murat Buyuksekerci, Servet Iritas, Engin Tutkun, Omer Hinc Yilmaz. Elevated neutrophil lymphocyte ratio and T4 levels can be predisposing factors for silicosis. Eur Respir J 2016; 48: Suppl. 60, 4282

Member's Comments

No comment yet.

Related content which might interest you: Elevation of serum napsin A levels in patients with hypersensitive pneumonia Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 High levels of vascular endothelial growth factor–C and D are associated with disease severity of hypersensitivity pneumonitis Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Seasonal variation of serum KL-6 levels in patients with interstitial lung diseases Source: International Congress 2014 – ILDs 1 Year: 2014 Serum B cell activating factor (BAFF) as a prognostic biomarker in interstitial lung diseases associated with connective tissue diseases Source: International Congress 2014 – ILDs: connective tissue disease Year: 2014 Serum biomarkers as prognostic factors of autoimmune pulmonary alveolar proteinosis after whole lung lavage Source: International Congress 2016 – Orphan diseases I Year: 2016 Comparative role of serum cathepsin S concentrations for differential diagnosis of sarcoidosis from other lung diseases Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 MUC1 gene polymorphisms are associated with serum KL-6 levels and pulmonary dysfunction in pulmonary alveolar proteinosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Markers of injury and fibrosis in occupational interstitial lung diseases (OILD) Source: International Congress 2015 – Occupational disease: clinical cases and series Year: 2015 Late Breaking Abstract - Increased serum levels of YKL-40 in male smoking chronic obstructive pulmonary disease patients associated with altered miRNA levels in alveolar macrophages Source: Virtual Congress 2020 – New biomarkers for management of obstructive diseases Year: 2020 Cytokines and MMP-9 level in serum and induced sputum of patients with suspicion of occupational COPD Source: International Congress 2016 – Occupational and environmental exposures and biomarkers: human studies, animal data, and in vitro methods Year: 2016 Systemic inflammatory markers in COPD: results from the Bergen COPD Cohort Study Source: Eur Respir J 2010; 35: 540-548 Year: 2010 Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Circulating monocytes from interstitial lung disease patients show an activated phenotype Source: International Congress 2016 – ILD: from the bench to the bedside Year: 2016 Prevalence and trafficking of circulating fibrocytes in smoking-related fibrogenic lung diseases Source: International Congress 2015 – Pulmonary fibrosis: mechanisms of disease Year: 2015 iNKT cells are inversely related to β-glucan in BALF and granuloma formation in patients with sarcoidosis Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015 Different changes in plasma concentrations of cytokines and chemokines in patients with COPD associated with smoking and occupational exposures Source: International Congress 2016 – Human responses to exposure, including physiological and biomarker outcomes Year: 2016 Prognostic significance of neutrophil to lymphocyte ratio in chronic obstructive pulmonary disease Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014 Circulating fibronectin to C-reactive protein ratio and mortality: a biomarker in COPD? Source: Eur Respir J 2008; 32: 1451-1457 Year: 2008 Transforming growth factor B1 polymorphism and serum levels in interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015 Annual changes in pulmonary function are independent prognostic factors for the patients with chronic hypersensitivity pneumonia Source: International Congress 2014 – ILDs 3 Year: 2014